Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517947 | SCV000615847 | benign | not specified | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001398816 | SCV001600591 | likely benign | not provided | 2020-08-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490892 | SCV002798716 | likely benign | Focal segmental glomerulosclerosis 2 | 2022-05-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003900082 | SCV004708659 | likely benign | TRPC6-related disorder | 2022-12-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |